Ambulero
Omaida Caridad Velazquez is the Chief Medical Officer at Ambulero.
Omaida is a Professor and Chair, DeWitt Daughtry Family Department of Surgery, David Kimmelman Endowed Chair in Vascular Surgery, Surgeon-in-Chief for UMHS Health System & Jackson Health System, Leonard. M. Miller School of Medicine, University of Miami. She is the PI of an NIH-funded basic science laboratory investigating vascular biology, angiogenesis, and vasculogenesis. Dr. Velazquez is the author of 20 books/monographs, more than 100 journal articles, has received 35 funded research grants.
This person is not in any offices
Ambulero
Ambulero is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease. A platform company that can deliver the adhesion molecule E-selectin using different cell and synthetic vector technologies.